These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19298232)

  • 1. Importance of medication adherence from the ONTARGET and TRANSCEND points of view.
    Barrios V; Escobar C; Echarri R
    Fundam Clin Pharmacol; 2009 Apr; 23(2):259-60. PubMed ID: 19298232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
    Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
    Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy?
    Agarwal S; Tang SS; Rosenberg N; Pettitt D; McLaughlin T; Joyce A; Schwartz JS
    Am J Ther; 2009; 16(2):119-26. PubMed ID: 19114872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' ability to predict patients' adherence to antihypertensive medication in primary care.
    Zeller A; Taegtmeyer A; Martina B; Battegay E; Tschudi P
    Hypertens Res; 2008 Sep; 31(9):1765-71. PubMed ID: 18971555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor blood pressure control: what physicians can do to improve it.
    Rakel RR
    Postgrad Med; 2000 Oct; 108(5 Suppl):19-24. PubMed ID: 19667537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent resistant hypertension and medication adherence.
    Ahmed MI; Calhoun DA
    Hypertens Res; 2011 Jan; 34(1):41-2. PubMed ID: 21107331
    [No Abstract]   [Full Text] [Related]  

  • 9. Adherence to medication: the importance of research in primary care.
    Prado JC; Mion D
    Am J Hypertens; 2010 Feb; 23(2):109. PubMed ID: 20087323
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing 'resistance': is adherence a target for treatment?
    Burnier M
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):439-43. PubMed ID: 25036746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for single-pill triple therapy in hypertension.
    Elijovich F; Laffer C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):231-40. PubMed ID: 19443512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the content of the knowledge on adherence to medication in hypertensive patients.
    Karaeren H; Yokuşoğlu M; Uzun S; Baysan O; Köz C; Kara B; Kirilmaz A; Naharci I; Pinar M; Yilmaz MB; Uzun M
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):183-8. PubMed ID: 19520651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and adherence to antihypertensive medication in patients from primary care.
    Zeller A; Schroeder K; Peters T
    Eur J Gen Pract; 2007; 13(3):161-2. PubMed ID: 17853178
    [No Abstract]   [Full Text] [Related]  

  • 18. [The acute phase of stroke. Treating hypertension or not?].
    Schrader J; Kulschewski A
    MMW Fortschr Med; 2003 Jan; 145(1-2):41-2. PubMed ID: 12638438
    [No Abstract]   [Full Text] [Related]  

  • 19. Fifty years of thiazide diuretic therapy for hypertension.
    Moser M; Feig PU
    Arch Intern Med; 2009 Nov; 169(20):1851-6. PubMed ID: 19901136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical aspects of treatment discontinuation and adherence.
    Parati G; Bilo G
    J Hypertens Suppl; 2009 Jun; 27(2):S18-21. PubMed ID: 19491617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.